Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
Express News | Jefferies Reinstates Buy on Viatris, Announces $15 Price Target
Viatris Analyst Ratings
Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15
Big Pharma Rally After J&J Earnings
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
BofA Securities Maintains Viatris(VTRS.US) With Sell Rating
Express News | Viatris Inc : BofA Global Research Cuts Price Objective to $11 From $12
Express News | Reported Thursday, Calliditas Therapeutics And Viatris Initiate Phase III Clinical Trial Of Nefecon For IgA Nephropathy In Japan
Express News | Viatris Brings to Completion All Previously Announced Divestitures With the Closing of Its Over-the-Counter Business Divestiture
Viatris Has Closed the Divestiture of Its Over-the-Counter Business to Cooper Consumer Health >VTRS
Express News | Viatris Shares up 1.7% Premarket After US DOJ Informs Co's Mylan No Longer Part of Antitrust Investigation
Express News | Viatris Inc - DOJ Civil Division to Take No Further Action on Mylan
Express News | U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
Express News | Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of Its Over-the-Counter Business to Cooper Consumer Health
EU: Meeting Conditions Would Address Competition Concerns of Merger
Express News | EU Approval Conditional on Cooper Selling Rights and Interests in Infant Laxative Medicine and Earwax Removal Product
Express News | Cooper Consumer Health Gains EU Antitrust Approval to Buy Viatris' European Over-the-Counter Drug Business
Viatris Named to TIME's World's Most Sustainable Companies 2024 List